Free Trial
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free BFRIW Stock Alerts

Biofrontera (BFRIW) Competitors

Biofrontera logo
$0.0070 0.00 (0.00%)
As of 10/8/2026 03:59 PM Eastern
Compare

BFRIW vs. SXTPW, CALA, CINGW, CLVR, and CMRAW

Should you buy Biofrontera stock or one of its competitors? Biofrontera's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Calithera Biosciences (CALA), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Biofrontera compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Biofrontera. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for Biofrontera. 60 Degrees Pharmaceuticals' average media sentiment score of 0.99 beat Biofrontera's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
60 Degrees Pharmaceuticals
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Biofrontera
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Biofrontera on 2 of the 3 factors compared between the two stocks.

How does Biofrontera compare to Calithera Biosciences?

Biofrontera (NASDAQ:BFRIW) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Biofrontera has higher revenue and earnings than Calithera Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Calithera Biosciences N/A N/A N/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Biofrontera's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biofrontera
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Calithera Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Biofrontera beats Calithera Biosciences on 1 of the 1 factors compared between the two stocks.

How does Biofrontera compare to Cingulate?

Biofrontera (NASDAQ:BFRIW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

In the previous week, Biofrontera had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Cingulate. Biofrontera's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Cingulate Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Biofrontera beats Cingulate on 2 of the 2 factors compared between the two stocks.

How does Biofrontera compare to Clever Leaves?

Biofrontera (NASDAQ:BFRIW) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

Biofrontera has higher revenue and earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A

In the previous week, Biofrontera had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Clever Leaves. Biofrontera's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Clever Leaves Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Clever Leaves N/A N/A N/A

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Biofrontera and Clever Leaves tied by winning 2 of the 4 factors compared between the two stocks.

How does Biofrontera compare to Comera Life Sciences?

Biofrontera (NASDAQ:BFRIW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Comera Life Sciences N/A N/A N/A

In the previous week, Biofrontera had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Biofrontera and 0 mentions for Comera Life Sciences. Biofrontera's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Comera Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Summary

Biofrontera beats Comera Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRIW vs. The Competition

Export
MetricBiofronteraPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.36B$7.20B$13.29B
Dividend YieldN/A2.65%2.53%16.36%
P/E RatioN/A797.67274.6426.12
Price / SalesN/A834.22585.8480.79
Price / CashN/A86.1776.8253.72
Price / BookN/A10.7611.216.31
Net IncomeN/A$2.84B$3.50B$381.90M
7 Day PerformanceN/A-0.74%-0.91%-1.34%
1 Month PerformanceN/A-5.64%-5.40%-4.29%
1 Year PerformanceN/A-5.05%4.60%-0.30%

Biofrontera Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
N/A$0.01
flat		N/A-93.2%$0.00$46.18MN/A94
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-46.8%$0.00$1.11MN/A3
CALA
Calithera Biosciences
N/A$0.00
flat		N/A+0.0%$0.00N/AN/A60
CINGW
Cingulate
N/A$0.00
+34.3%		N/AN/A$0.00N/AN/A14
CLVR
Clever Leaves
N/AN/AN/AN/A$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BFRIW) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel